SYPEQIA

Swiss trademark · 809784 · Word mark · In force

Register entry

Registration number
809784
Application number
01362/2024
Status
In force
Type
Word mark
Filed
Jul 20, 2021
Registered
Feb 9, 2024
Published
Feb 9, 2024
Protected until
Jul 20, 2031
Priority
21.01.2021 US
Remarks
Transformation totale de l'enregistrement international n° 1614123 (art. 46a LPM).
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Préparations pharmaceutiques pour le traitement de cancers, troubles auto-immuns, troubles inflammatoires, ainsi que pour le traitement et la prévention de réactions du greffon/du receveur.

Medical, beauty and agricultural services

Mise à disposition d'informations en matière de soins de santé.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 31, 2024

    Merged

    Owner
    CTI Biopharma Corp., 3101 Western Avenue, Seattle WA 98121, USA → Sobi, Inc., 77 4th Avenue, 3rd Floor, Waltham, MA 02451, USA

    Published in Swissreg on 31.10.2024

  2. Feb 9, 2024

    Registered

    Published in Swissreg on 09.02.2024

Parties

Holder

Sobi, Inc.

77 4th Avenue, 3rd Floor, Waltham, MA 02451, US

Agent

Schaad, Balass, Menzl & Partner AG

Schaad Balass Menzl & Partner AG Patent- und Markenanwälte

Bellerivestrasse 20, 8034 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.